Long-Term Efficacy and Safety of Luspatercept in Lower-Risk   Myelodysplastic Syndromes (MDS): Phase 2 PACE-MDS Study

Title:: Long-Term Efficacy and Safety of Luspatercept in Lower-Risk Myelodysplastic Syndromes (MDS): Phase 2 PACE-MDS Study
Document type:: Meeting Abstract
Author(s):: Platzbecker, Uwe; Kiewe, Philipp; Germing, Ulrich; Goetze, Katharina; Mayer, Karin; Radsak, Markus; Wolff, Thomas; Chromik, Joerg; Reynolds, Joseph; Barron, Carolyn; Zhang, Xiaosha; Laadem, Abderrahmane; Attie, Kenneth; Giagounidis, Aristoteles
Journal title abbreviation:: Clin Lymphoma Myeloma Leuk
Year:: 2020
Journal volume:: 20 Suppl 1
Pages contribution:: S319-S320
Print-ISSN:: 2152-2650
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: